Global Neutron Capture Therapy of Cancer Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Neutron Capture Therapy of Cancer Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Neutron capture therapy (NCT) is a type of radiotherapy for treating locally invasive malignant tumors such as primary brain tumors, recurrent cancers of the head and neck region, and cutaneous and extracutaneous melanomas. It is a two-step processfirst, the patient is injected with a tumor-localizing drug containing the stable isotope boron-10 (10B), which has a high propensity to capture low energy "thermal" neutrons. The neutron cross section of 10B (3,837 barns) is 1,000 times more than that of other elements, such as nitrogen, hydrogen, or oxygen, that occur in tissue. In the second step, the patient is radiated with epithermal neutrons, the sources of which in the past have been nuclear reactors and now are accelerators that produce higher energy epithermal neutrons.
Neutron Capture Therapy of Cancer report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neutron Capture Therapy of Cancer market is projected to reach US$ 248 million in 2033, increasing from US$ 84 million in 2022, with the CAGR of 13.5% during the period of 2023 to 2033. Demand from Brain Tumor and Extracranial Tumor are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neutron Capture Therapy of Cancer industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Neutron Capture Therapy of Cancer key companies include TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc. TAE Life Sciences, RaySearch, Neutron Therapeutics are top 3 players and held % share in total in 2022.
Neutron Capture Therapy of Cancer can be divided into Thermal Beam and Epithermal Beam, etc. Thermal Beam is the mainstream product in the market, accounting for % share globally in 2022.
Neutron Capture Therapy of Cancer is widely used in various fields, such as Brain Tumor, Extracranial Tumor and Others,, etc. Brain Tumor provides greatest supports to the Neutron Capture Therapy of Cancer industry development. In 2022, global % share of Neutron Capture Therapy of Cancer went into Brain Tumor filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Neutron Capture Therapy of Cancer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Segment by Type
Thermal Beam
Epithermal Beam
Brain Tumor
Extracranial Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neutron Capture Therapy of Cancer market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Neutron Capture Therapy of Cancer introduction, etc. Neutron Capture Therapy of Cancer Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Neutron Capture Therapy of Cancer market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Neutron Capture Therapy of Cancer report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neutron Capture Therapy of Cancer market is projected to reach US$ 248 million in 2033, increasing from US$ 84 million in 2022, with the CAGR of 13.5% during the period of 2023 to 2033. Demand from Brain Tumor and Extracranial Tumor are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neutron Capture Therapy of Cancer industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Neutron Capture Therapy of Cancer key companies include TAE Life Sciences, RaySearch, Neutron Therapeutics, International Particle Therapy, Southern TOHOKU Hospital Group and Neuboron Medtech, etc. TAE Life Sciences, RaySearch, Neutron Therapeutics are top 3 players and held % share in total in 2022.
Neutron Capture Therapy of Cancer can be divided into Thermal Beam and Epithermal Beam, etc. Thermal Beam is the mainstream product in the market, accounting for % share globally in 2022.
Neutron Capture Therapy of Cancer is widely used in various fields, such as Brain Tumor, Extracranial Tumor and Others,, etc. Brain Tumor provides greatest supports to the Neutron Capture Therapy of Cancer industry development. In 2022, global % share of Neutron Capture Therapy of Cancer went into Brain Tumor filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Neutron Capture Therapy of Cancer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
TAE Life Sciences
RaySearch
Neutron Therapeutics
International Particle Therapy
Southern TOHOKU Hospital Group
Neuboron Medtech
Segment by Type
Thermal Beam
Epithermal Beam
Segment by Application
Brain Tumor
Extracranial Tumor
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neutron Capture Therapy of Cancer market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Neutron Capture Therapy of Cancer introduction, etc. Neutron Capture Therapy of Cancer Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Neutron Capture Therapy of Cancer market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.